• Publications
  • Influence
The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells.
As the primary physiological barrier, intestinal epithelial cells regulate the transportation of oral therapeutic agents including nanomedicines which significantly improves the bioavailability ofExpand
  • 139
  • 8
The transport pathways of polymer nanoparticles in MDCK epithelial cells.
Epithelial cell membranes as the typical biological barrier constitute the prime obstacle for the transport of therapeutic agents including nanomedicines. The previous studies on the interactionExpand
  • 66
  • 3
Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
As an attractive strategy developed rapidly in recent years, nanocrystals are used to deliver insoluble drugs. PEGylation may further prolong the circulation time of nanoparticles and improve theExpand
  • 49
  • 3
  • PDF
A novel localized co-delivery system with lapatinib microparticles and paclitaxel nanoparticles in a peritumorally injectable in situ hydrogel.
The combination of high dose of oral lapatinib (LAPA), a HER2 tyrosine kinase inhibitor, with intravenous paclitaxel (PTX) exhibited a clinical survival advantage compared with PTX alone against HER2Expand
  • 33
  • 3
Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Cyclosporine A (CyA) is a poorly soluble peptide and the available preparation is the surfactant based Sandimmum Neoral(®). In this study, we developed a novel pH-sensitive nanomatrix system of CyAExpand
  • 15
  • 3
Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
  • Z. Lin, Wei Gao, +7 authors Q. Zhang
  • Chemistry, Medicine
  • Journal of controlled release : official journal…
  • 28 January 2014
As a sustained-release drug depot for localized cancer treatment, in situ thermo-sensitive hydrogel has attracted increasing interests. However, it is currently a big challenge to achieve highExpand
  • 117
  • 2
Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy.
Based on the hydrophobic interaction with biomembranes, PFVYLI (PFV), a hydrophobic penetration peptide (HPP), was initially introduced to modify doxorubicin-loaded stealth-sustained liposomesExpand
  • 66
  • 2
Targeting efficiency of RGD-modified nanocarriers with different ligand intervals in response to integrin αvβ3 clustering.
Receptor change induced by ligand binding is a new issue to face in the field of targeted delivery. Receptor clustering, the main pattern of receptor changes, decreases the affinity between ligandExpand
  • 72
  • 2
Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and
To address the obstacles facing cancer chemotherapeutics, including toxicity, side effects, water insolubility, and lack of tumor selectivity, a novel stimuli-responsive drug-delivery system wasExpand
  • 58
  • 2
Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.
The purpose of this study was to develop a targeted combinatorial polymeric micelle system that can sequentially kill tumor vasculature and tumor cells and increase the anticancer efficacy. TowardExpand
  • 58
  • 2